key: cord-0009832-c68483gk
authors: BARDIN, P. G.; JOHNSTON, S. L.; PATTEMORE, P. K.
title: Viruses as precipitants of asthma symptoms II. Physiology and mechanisms
date: 2006-04-27
journal: Clin Exp Allergy
DOI: 10.1111/j.1365-2222.1992.tb02825.x
sha: 34ab511f5ea4aa866731abdbcab45695456e4783
doc_id: 9832
cord_uid: c68483gk

nan

Clinical observation and anecdotal evidence have long indicated a relationship between the development of an upper respiratory tract viral infection (a 'cold') and exacerbations of asthma symptoms. Indeed, many patients relate the start of their disease to a particularly severe bout of "flu" or a cold. Prospective studies have indicated that asthma attacks are associated with a viral infection in as many as 20-50% of cases [1.2] , although the symptoms may sometimes be difficult to distinguish clinically from various forms of rhinitis and hay fever. Epidemiological evidence reviewed in a previous article [y\ confirm a close temporal association between exacerbations of asthma and intercurrent viral infections. Unlike bacteria, viruses are associated with wheezing Illnesses in populations, in individuals, and in time and are rarely cultured from the airways during asymptomatic periods. The predominant viruses causing wheezing are human rhinovirus (HRV) and respiratory syncytial virus (RSV), although the causative viral agent may vary according to age. Difficulties with the diagnosis of HRV infections are likely to have contributed to a lower reported than actual incidence of this virus and it is possible that this virus plays a more important role in the induction of asthma attacks than is currently appreciated. The mechanisms whereby upper respiratory viruses might induce or contribute to attacks of asthma arc currently unknown. It is the purpose of this review to examine the evidence available and to discuss the merits of the various mechanisms so far proposed. A further article will describe some recent advances in the molecular aspects of HRV infection and KRV diagnosis and will discuss briefly some therapeutic implications for the asthmatic patient.

Although acute viral respiratory illnesses account for up to 53% of acute conditions seen in the USA annually [4] , Correspondence: Dr P. G. Bardin the Study of the relationship between the infecting agent and pulmonary pathophysiological mechanisms is still poorly understood. Evidence has accumulated steadily that viruses may be instrumental in the origin and/or exacerbation of asthma, but investigations have been hampered both by difficulties in establishing a viral origin in patients who manifest clinically significant bronchial symptoms such as cough, wheezing or sputum production, and by difficulties in obtaining endobronchial tissue for studies of the histology and the microanatomical changes associated with viral infections. A relationship between upper airway infection and the simultaneous or subsequent development of lower airway symptoms is often observed in the clinical situation, but how this occurs and how the tower airway abnormalities are caused remain ill-defined. There are many theoretical mechanisms whereby viruses might induce or exacerbate lower airway disease. These may be conveniently divided into (1) those proposing a virus infection that involves both the upper and lower respiratory tracts, and leads directly to the pathophysiological changes observed, and (ii) those proposing a virus infection confmed to the upper respiratory tracts, which by indirect or remote means results in pathophysiological changes in the lower respiratory tracts. The mechanisms operating may vary according to the type of virus causing the infection, as well as the characteristics of the host and a combination of many of the proposed mechanisms appears likely. The chief mechanisms so far proposed are summarized in Table 1 and are discussed more fully below.

Some viral infections are known to cause severe pathological abnormalities in the lower airways and throughout the entire respiratory tract. Influenza A infection induces diffuse inflammation of the bronchi, trachea and larynx with desquamation of ciliated epithelial cells down to a one-cell-thick basal layer [5] . This is accompanied by submucosal oedema coupled to infiltration by neutrophils and mononuclear cells with complete resolution of 809 [6] . and ciliary defects in the nasal mucosa of children with infections with influenza types A and B. parainfluenza typ)es 1. 2 and 3, adenovirus. RSV and herpes simplex virus, though not in the single case of rhinovirus infection studied [7] . Rhinoviruses appear to cause little or only patchy epithelial damage [8] . A study with human nasal cultured epithelium demonstrated a marked cytopathic effect followed by destruction ofthe cell monolayer with both adenovirus and influenza type A infections, while no cytopathic effect was observed with rhinovirus and coronavirus infections., despite active viral replication being demonstrated [9] . In addition, nasal biopsies from subjects with HRV colds show no definitive histopathological changes, although hyperaemia and exudation of seromucinous fluid is found coupled to cytological changes such as epithelial metaplasia, and is accompanied by impaired mucociliary flow rates [10] , a feature reproduced in a separate study [1 1] . Studies in organ cultures of bovine tracheal epithelium show marked changes in epithelial microstructure after bovine rhinovirus infection [12] . Desquamation of ciliated epithelial cells was evident leaving a smooth epithelial surface with relatively few remaining cihated cells. This pattern of mucosal damage was also suggested by the increase in ciliated epithelial cells found in nasal secretions after experimental HRV infection in volunteers [13] . There are several mechanisms by which virus induced epithelial damage might result in deleterious effects in asthmatic patients. Exposure of rapid-adapting sensory parasympathetic fibres could cause bronchoconstriction via increased efferent vagal activity [14] , a theory supported by Empey el al. [15] to explain increased chollnergic responses found in normal subjects after virus infection. Similarly the penetration of allergen into the epithelium would be facilitated both by epithelial stripping, and by reduced ciliary clearance, resulting in easier access of allergen to antigen presenting cells and therefore increased allergic inflammation. The epithelium is also an important source of regulatory proteins or mediators with protective roles, such as epithelium derived relaxant factor [16] or bronchodilator prostaglandins E^ and h, which may play a role in maintaining bronchial patency [17] .

Neuropeptides are thought to play a role in the pathogenesis of asthma [18] , and are broken down by neutral endopeptidases found in airway epithelium. Destruction of neutral endopeptidases by virus induced epithelial damage might result in increased levels of neuropeptides. and therefore increased neurogenic inflammation [19] .

New evidence also suggests that sequential viral induced parenchymal lung damage may be cumulative as demonstrated after infection of Swiss mice by parainfluenza I virus followed by Influenza A 30 days later [20] . Repeated viral infections inducing endobronchial inflammation may conceivably lead to marked structural and functional changes in airway epithelium and submucosal tissues; abnormalities that may not be totally reversible when the infection resolves. In patients with pre-existing airway disease (bronchiectasis. asthma) who may be predisposed to repeated viral infections, this may have devastating long-term consequences.

Damage to the airway epithelium by viruses has been proposed by Empey et al. [15] to explain increased cholinergic responses in normal subjects after infection because loss of epithelial cells may expose rapid-adapting sensory parasympathetic fibres which could cause bronchoconstriction via increased efferent vagal activity [14] . They demonstrated the development of bronchial hyperresponsiveness to histamine in the infected group which was prevented by pretreatment with inhaled atropine and reversed by a beta-agonist (isoproterenol), suggesting a role for vagal over-activity after viral infection. Further evaluation of this possible mechanism has not been carried out although similar observations were made after vagus nerve transection in parainfluenza-3 infected guinea-pigs [70] , The animals' airways also exhibited increased degrees of obstruction when the transected nerve was stimulated, suggesting that the efferent limb of the vagus nerve was altered along with afferent limb and contributed to the increases in BHR. There have not been any reports linking abnormalities of smooth muscle function in the airways to viral infections.

The pathological changes described after viral infections bear many similarities to those found in asthma and it is easy to envisage how pre-existing airway inflammation and obstruction could be exacerbated by a further inflammatory stimulus such as viral infection. Release of tissue-damaging substances from leucocytes and other cells may be one mechanism involved in this process.

It was originally thought that respiratory viruses may produce endobronchial inflammation via epithelial denudation, cell death and the resultant release of tissue damaging enzymes (such as lysosomal enzymes). However, recent evidence indicates that viruses may have the capacity to directly induce the release of pro-inflammatory mediators from alveolar macrophages, neutrophils, eosinophils and mast cells and may augment superoxide production.

Hi.stamine Several studies have demonstrated that histamine release from leucocytes (including basophils and mast cells), following immunological and non-immunological stimuli, is increased by infection or incubation with a variety of respiratory viruses including influenza A, rhinovirus parainfluenza virus and RSV [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] , Recent work with parainfluenza viruses in Brown Norway rats [32] has demonstrated increased release of histamine coupled to a virus-induced increase in bronchiolar mast cells.

Although the exact role of mast cells and basophils in the pathogenesis of airway inflammation is still uncertain, increased release of inflammatory mediators in the airways from mast cells (or basophils) may have a profound effect in already inflamed airways and contribute to exacerbation of airway obstruction. It has been suggested that basophils migrate from the peripheral circulation to the airways during an attack of asthma [33] . Lett-Brown et al. [34] also demonstrated that basophilic chemotactic responses are selectively enhanced after in vivo incubation of leucocytes with parainfluenza virus and this observation raises the possibility that viruses may not only increase mediator release but also replenish airway inflammatory cell populations.

Interferon An early study by Ida [22] suggested that interferon may be an important factor mediating viral enhancement of histamine release after immunological stimulus. This work was corroborated by Chonmaitree [23] and extended by Busse, who showed that T-cell depletion attenuated the enhanced histamine release from peripheral blood mononuclear cells following incubation with influenza A [24] , but that interferon did not alter histamine release after non-immunological stimulation [21] . Viral infections and interferon have also both been shown to increase the biosynthesis of prostaglandins in the macrophage [35] .

Bradykinin Bradykinin and lysylbradykinin are potent inflammatory mediators causing vasodilatation, increased vascular permeability and glandular secretion and stimulate pain production via neuronal reflexes [36] . Using HRV39 and HRV HH, Naclerio ei al. [37] have shown that there is a close association between symptoms of a cold and rises in the levels of bradykinin and lysylbradykinin in nasal secretions and that albumin levels increase, probably reflecting increased vascular permeability. Similarly, infection of the bronchial epithelium by HRVs might release bradykinin and lysylbradykinin and explain the frequent occurrence of lower airway symptoms such as cough and wheeze and the development or ampUfication of BHR. Sutprisingly, the levels of histamine and PGD; in nasal washes were normal implying that significant mast cell degranulation had not occurred.

Complement Influenza viral infections cause considerable tissue damage to the upper and lower airway as evidenced by epithelial desquamation and infiltration of leucocytes and mononuclear cells [5] . Recent investigation has implicated complement, a central mediator of inflammation, in the pathogenesis of influenza viral infections and demonstrated increases in C3a and C5a in human volunteers after infection with Influenza A virus [38] . The binding of complement components to epithelial cells had earlier been described in vitro [39] and in vivo [40] during infection with RSV, and provides an illustration of the ability of viruses to instigate and propagate inflammation via the release of chemotactic and cell activating factors from airway cells or via transudation from the bloodstream.

Lipoxins Lipoxins (LX) are a newly discovered class of trihydroxy-conjugated letraene derivatives of arachidonic acid produced in human leucocytes including eosinophils [41] as well as by alveolar macrophages [42] . Biological properties include contraction of lung parenchymal strips [43] , activation of protein kinase C [44] . decreased natural killer cell activity [45] and superoxide anion production by human leucocytes [46] . Kim [47] has recently demonstrated that alveolar macrophages obtained from rats inoculated with a spectrum of rodent viruses exhibited marked increases in LX production. The author proposed that LX are putative yet undocumented novel inflammatory mediators and immunomodulators associated with viral infections. Recently the presence of LXA4 was reported in BAL from patients with selected pulmonary diseases including pneumonia and asthma [48] .

Other lipid mediator.s and superoxide In the study of Naclerio et al. [37] . neutrophil numbers were markedly increased in nasal lavages. in keeping with an earlier study of nasal biopsy specimens after HRV infection, showing infiltration of the mucosa with inflammatory ceils including abundant neutrophils [49] , and with the findings of Levandowski who also found increased numbers of neutrophils and lymphocytes in nasal lavage in the presence of HRV infection [50] . Recent tn vitro observations have indicated that neutrophils exhibit enhanced adhesion 10 airway epithelial cells infected with human parainfluenza viruses [51] and recruitment of such cells could contribute further to a perpetuation of inflammation via secretion of lipid mediators, proteases and oxygen radicals. Indeed Faden et ai demonstrated increased superoxide production and release of thromboxane B? from neutrophils incubated with RSV antibody complexes [52] .

Antibody dependent enhancement Viral infections do not lead to marked immunological responses from the body after infection. Although it is known that both humoral and cellular immunity is activated, it is doubtful whether humoral responses are essential for recovery from viral illness as suggested by rises in local and neutralizing antibody after resolution of the clinical illness [4] . Indeed there is evidence to suggest that in RSV infection the severity of infection may be increased by subncutralizing antibody titres. a phenomenon called antibody dependent enhancement [53] . It is postulated that low levels of antibody insufficient to neutralize the virus will bind and facilitate viral entry into cells, such as macrophages, bearing Fc receptors. The infected macrophage can then promote the spread of the viral infection to other parts of the respiratory tract, in addition to allowing viral replication to take place. Recent studies have provided support for this theory, demonstrating by means of northern blot analysis, the replication of RSV in human alveolar macrophages [54] , and showing that asthmatic subjects have higher baseline IgA and IgG. and a greater response of IgA to attenuated influenza infection, than do normal subjects [55] . The same study also postulated a role for the increased levels of antibody in asthmatic subjects in promoting inflammation via eosinophil antibody-dependent cytotoxicity.

Systemic cellular immune responses Uncertainty surrounds the role of systemic cellular immune responses after viral infection. Levandowski et al. demonstrated decreases in numbers of circulating T-lymphocytes in peripheral blood after HRV infection and proposed that this may be related to recruitment of these cells to the nasal mucosa where they may perform a local immunological function [56] , they then went on to demonstrate increased numbers of lymphocytes in the nasal secretions during HRV infection [39] . Other have suggested that lhis decrease may be related to increased levels of interferon-y [57] . Cytokine production from T-tymphocytes has implied a pivotal role for these cells in the orchestration of inflammatory processes and viruses may exert a profound influence on the induction and modulation of inflammation in the airways via interference with this mechanism. In asthmatics pre-existing endobronchial inflammation may be amplified by viral-induced release of cytokines such as IL-3 and IL-5 from lymphocytes, accounting for eosinophil maturation and recruitment to the bronchia! mucosa coupled to [gE increases mediated by IL-4 secretion [58] . Indeed in vitro evidence has recently been provided for just such a process, with increased numbers of low density eosinophils being demonstrated after incubation with influenza virus and HRV [59] . It has also recently been shown that RSV induces eosinophil degranulation and release of eosinophil cationic protein in nasopharyngeal secretions from children with bronchiolitis, but not with bacteria! pneumonia [60] .

In a study combining local antigen challenge and broncho-alveolar lavage (BAL) prior to, during and after HRV 16 experimental infection, the viral infection alone did not induce significant inflammatory changes as assessed by BAL in either nonnal or allergic rhinitic subjects [61] . However, after segmental antigen bronchoprovocation there was an increase in eosinophils. protein exudation and total BAL cell count, in the allergic rhinitic subjects, suggesting that allergic airway inflammation had been virally modu!ated, possib!y by potentiating antigen-induced re!ease of various proinflammatory and chemotactic substances. The mechanisms entai!ed in these observations are at present speculative but raise the possibility that asthmatic airways may react in a unique fashion to viral infections exhibiting a greater tendency to amplification of inflammatory bronchial events when challenged with antigen.

Cytokines Support for this hypothesis has come from in vitro studies by Hsia et al. [62] of peripheral blood mononuclear cells after experimental human infection with an unnumbered HRV. The cellular immune response was evaluated by measuring IL-2 and IFN-y production alter mitogen stimulation, assessment of natural killer cell activity and via specific antigen stimulation blastogenesis measured at baseline, on days 1-5 of virus infection and alter resolution of infection. IL-2 production increased over baseline by a factor of 4 and was inversely related to the duration of virus shedding. Interestingly, the level of increase in IL-2 was unrelated to total symptom scores or convalescent antibody titres. IFN-y production was also increased but to a much smaller extent compared to baseline (factor of 2). whilst natural killer cell cytolytic activity was also amplified. pH]thymidine incorporation by cells was increased in thepresence of HRV antigen and directly related to mucus production and days of viral shedding. The results suggest an important role for at least one cytokine (IL-2) in viral infections and further studies may extend this to other products of lymphocyte and macrophage activation. Lymphocyte activation as measured by blastogenic responses has been found in other studies 163] and may be a marker for the activation of viral specific cellular immune responses contributing to symptoms as well as inflammatory sequelae of this type of infection. An earlier study by Welliver and colleagues found increased lymphocyte activation in subjects who wheezed during the 6 months after infection with RSV, when compared to subjects with no wheeze after RSV infection 164].

Viruses may contribute to the development of wheezing in asthmatic patients partly as a result of a decrease in [iadrenergic function. Sympathetic /i-receptors are found on airway smooth muscle as well as on circulating leucocytes and stimulation of adrenergic airway receptors opposes parasympathetic effects on the airways. An imbalance of this mechanism has been proposed as being a fundamental abnormality in asthma [65] . It has been shown that asthmatics exhibit abnormal metabolic 166.67] and physiological [68] responses to adrenergic stimulation and il has been postulated that viruses may exacerbate this abnormality. Busse and colleagues [69] in a study of in vitro leucocyte responses after upper respiratory viral infection, reported decreased leucocyte /i-adrenergic receptor function and proposed that this may apply to the identical receptors on bronchial smooth muscle. An additional elTect of/3-agonistson leucocytes is a decrease of !ysosomal enzyme release and diminished (iã drenergic function may thus lead to infiammatory effects related to amplified liberation of tissue-damaging enzymes from dysfunctional neutrophils.

The above observations were confirmed by Buckner et al. [70] who used parainfluenza infected guinea-pigs to show a decrease in sensitivity to /?-agonist medication after viral infection in relation to antigen challenge but not to histamine or carbuchol. The mechanisms involved in this reduced sensitivity were investigated in mice, and found to be a result of attenuation of receptor and post receptor activation of adenylate cyclase activity [71] . The clinical relevance of such observations are still uncertain and further comprehensive studies of/^receptor function in the airways of normal and asthmatic subjects are required to enable extrapolation of these in vitro observations to human airways.

The work of WelHver er al. [72, 73] demonstrated that RSV infections induced the production of virus specific IgE bound to exfoliated respiratory epithelial cells and that the magnitude of this response correlated with subsequent wheezing, increased histamine in nasal secretions and the degree of arterial hypoxia. Children with a genetic atopic disposition appeared to develop elevated specific IgE antibody more readily and the authors speculated that viruses may induce asthma and other allergic disease on the basis of this genetically predetermined phenomenon. Further prospective studies have strengthened this impression, showing that only 28Vo of subjects with undetectable IgE to RSV had subsequent wheezing, whilst 70% with elevated RSV-IgE wheezed at a later stage 174]. The same workers have also demonstrated the production of specific IgE to parainfluenza virus [75] and ils relation to the severity of croup, wheezing and the ievels of histamine in the nasal secretions, while other workers have demonstrated the production of high titres of specific IgE in Mycopla.sma pneumoniae infections in asthmatic or allergic subjects [76] .

increased production of IgE induced by viral infections has significant implications in atopic diseases. Mast cell bound IgE will induce degranulation and mediator release on cross-linking of antibody by antigen. Recent studies have suggested a pivotal rote for the mast cell in inflammatory processes via the release of mediators [77] and the production of various cytokines [78] , all of which may lead to an amplification of inflammation in the already diseased airways of asthmatics who develop viral infections. The development of a seemingly innocent 'cold' in a genetically predisposed individual may set in motion a sequence of events that cause the emergence of a spectrum of allergic symptoms including severe lifethreatening airway obstruction. Viral-specific IgE production may be a factor linking these events.

Nasal blockage is a major symptom of upper respiratory viral infection, and is frequently severe enough to result in prolonged periods of enforced mouth breathing, particularly so in subjects with pre-existing rhinitis. Mouth breathing allows inspired air to pass directly into the lower respiratory tract without undergoing the normal conditioning performed by the nasal mucosa, resulting in the delivery of air at lower temperatures and lower humidity. These factors are known to play a role in the genesis of bronehospasm in exercise induced asthma, and may therefore play a role in the genesis of lower airway obstruction in viral upper respiratory infections. In addition to conditioning inspired air. the nasal mucosa also acts as a filter reducing the load of inhaled particles delivered to the lower airway. The absence of this protective mechanism in upper respiratory infections may increase the penetrance of inhaled allergen to the lower airway, resulting in further bronchospasm in those sensitized to the allergen. Neither of these two mechanisms have been extensively investigated, but both may play a role in the precipitation of asthma symptoms during upper respiratory viral illnessess.

Studies by Frick et al. [79, 80] have suggested an IgE immunoregulatory role for viral respiratory infections in children who are genetically prone to allergy and to increased production of IgE. They found a strong temporal association between infection with parainfluenza 3 virus and RSV and the development of symptoms and signs of allergy coupled to sharp rises in total IgE (< 5-50 U/ml within 3 months). Animal studies in dogs have also suggested that allergic manifestations such as facial dermatitis as well as IgE increases develop more frequently in dogs receiving viral vaceination compared to controls [79] . A similar study in mice showed that allergen challenge prior to, or after recovery from influenza A infection resulted in no detectable IgE production, while similar challenge during the acute phase of the illness resulted in significant IgE production [18] .

Transient modulation of the ratios of T-lymphocyte subsets has been demonstrated after booster immunization of live attenuated measles virus in humans with increases in T-helper cells as well as IgE levels [82] . and it is feasible that this was mediated by increased IL-4 production from the TH2 subset of the T-helper cell population [83] . An early study by Saryan et al. [84] suggested that a factor secreted by T cells from atopie individuals induced IgE synthesis in normal B-cells after incubation in culture. This Mnducer" was not present in cells from normal subjects and may reflect IL-4 mediated preferential IgE production resulting from an imbalance between the THi and THT subsets (possibly exacerbated by viral infection) in subjects with atopy.

Viral respiratory illnesses are frequently accompanied by fever and a biphasic response in the blood total leucocyte and lymphocyte counts, consisting of an initial fall and then a rise. It is postulated that these eflects may be mediated by a release into the general circulation of locally produced cytokines, resulting in the systemic symptoms of vira! illness such as fever, fatigue, myalgia and headache. The other well known elTects of many cytokines include increasing bone marrow production, and release into the circulation with activation of many diflerent inflammatory leucocytes, resulting in a systemic up-regulation of inflammatory responses. Patients with an inflammatory illness such as asthma may therefore suffer an exacerbation of their disease as a result of this up-regulation. However, as the levels of cytokines released into the general circulation are too small to be detected by currently available methods, there is no firm evidence to support this mechanism.

It is well accepted that viruses such as Influenza. Parainfluenza. RSV and Adenovirus cause lower respiratory tract disease including pneumonia and bronchiolitis. Recent interest in respiratory viruses has centred on HRV, of which more than 100 serotypes have now been described, and which are reported to cause 40-50% of all acute colds [4] . Clinical infection is characterized by the typical symptoms of a cold which is indistinguishable from that caused by other viruses and lower respiratory symptoms are frequently present, especially cough which was present in 86% [85] , 71 % [86] and 40% [87] of normal subjects with naturally occurring infection. Further proof of the importance of this group of viruses has come from experimental viral infection studies which have demonstrated the development of late asthmatic responses in a group of atopic subjects [88] . in addition to epidemiological studies that have strongly implicated HRV in exacerbations of asthma and as a cause of "wheezy bronchitis' in children [1,2.89] .

There is as yet no conclusive proof of the presence of HRV in the lower airways in epithelial or alveolar cells although Halperin et al. [90] did culture HRV from tracheal secretions obtained bronchoscopically; they could not exclude the possibility of contamination during instrumentation of the upper airway. Busse ei at. [61] performed bronchoalveolar iavage {BAL) in six normal and seven allergic rhinitic subjects before, during and after experimentally induced HRVI6 infection. BAL fluid analysis at all three stages showed no evidence of gross epitheHal damage or of other inflammatory changes, although total protein in the BAL was significantly increased after infection with HRVI6. Because the findings in BAL fluid may not reflect tissue events accurately and the cellular changes in the mucosa may be very mild, further interpretation will require careful biopsy-based studies to demonstrate HRV genomic presence as well as the histological characteristics of this infection in the lower respiratory tract.

Further evidence for lower airway HRV infection has come from Horn et at. [2] who investigated sputum, nasal and throat swabs from 22 children during 72 episodes of wheezy bronchitis, and showed thai HRVs could be isolated in 49% of all episodes and in 64'^;. of episodes of severe illness requiring corlicosteroids. Viral cultures from spulum were more often positive than either nose or throat swabs suggesting that viral replication had occurred in the lower airways. Cytopathic eflects (CPE) developed more quickly in cultures from expectorated sputum as compared to upper airway samples implying that more virus was present in the lower airways (though had they compared nasal aspirate samples rather than swabs, wilh spulum, they may have found no differences) and that detection in sputum was not simply due to contamination by upper airway secretions. Rhinoviruses were predominant and could be cultured throughout the study, a finding that may reflect their importance as respiratory pathogens as well as technical expertise and experience in the culture of this fastidious group of viruses. However, this work oniy presents indirect evidence for involvement of the lower airways via direct mucosal invasion by respiratory viruses. Optimal temperatures for growth of HRV are 33 C, the temperature of the nasal mucosa, and this has been advanced as an argument to support the possibility of infection being localized exclusively to the upper airways. Recent descriptions of air temperatures of less than 37"C in the tracheobronchial tree under certain breathing conditions would be a means for providing a suitable environment for viral replication in healthy subjects [91] , and in asthmatics.

Post-mortem studies have demonstrated that HRVs are able to infect patients with compromised immunity as in a patient with myelomatosis in whom RVt3 was recovered from three specimens of lung tissue 192]. Although HRV 13 was cultured with demonstration of prominent CPE in human diploid cells, no specific histological changes attributable to the viral infection was observed in tissue sections. Rhinovirus 47 was cultured post-mortem from an 11-month-old infant with a history suggestive of bronchial asthma who had died suddenly at night [93] , The findings of the rest of the post-mortem examination were consistent with death due to hypoxia and the authors postu!ated that sudden severe airway obstruction associated with asthma may have been precipitated by the coexistent viral infection. Thus, from these reports it seems likely that HRVs as well as other viruses can invade the respiratory epithelium. Other viruses are also able to infect lower airway cells in subjects with compromised immunity as demonstrated by Krueger e/fl/. [94] in subjects with AIDS. Transbronchial biopsies stained positive for human herpes virus-6(HHV-6) with the monoclonal antibody D12 against HHV-6P4I and this was confirmed by in situ hybridization. Cells predominantly aflected were cuboidal epithelial cells of apparently terminal bronchioli.

The importance of the actual presence of H RV or other viral genomic material in the lower airways is obvious. Mechanisms for the induction of endobronchial inflammation and tissue damage by a direct effect of cytokine production, release of proinflammatory mediators and locally increased IgE production are all feasible if the virus is present within lower airways cells. If not, other mechanisms have to be postulated including refiex neurogenic effects and systemic immunologica! changes that secondarily aflect the lung. Recent developments in immunohistochemistry and in situ hybridization will allow carefully controlled biopsy studies in diflerent groups of pulmonary pathologies to explore these possibilities and clarify viral-lower airway interactions.

Non-specific bronchia! hyperresponsiveness (BHR) may be defined as an increase above normal in both the ease and the magnitude of airway narrowing on exposure to a number of non-sensitizing bronchoconstrictive stimuli [95] . The role of measurements of BHR in the diagnosis and follow-up of asthma is controversial [96.97] , although it is widely accepted thai it may be useful as a non-invasive means to assess bronchial inflammation and to assist in the diagnosis of occupational asthma [98] . Although the specific mechanisms responsible for exacerbations of asthma during viral upper respiratory tract infections (URTIs) have not been defined, the development or amplification of BHR may represent a pathway whereby lower respiratory tract symptoms such as wheezing and cough appear in normal subjects and increase in severity in asthmatic patients. This possibility has been examined in studies that assessed BHR in relation to viral URTIs., and although results have varied as a result of differing methodologies., evidence indicates that viral URTIs can induce BHR in normal people and aggravate it in those in whom BHR is already present.

Early work in vivo in guinea pigs using parainfluenza type 3 (P-3) did not find an alteration by this virus of isolated guinea pig airway contractile responses to carbachol, histamine or specific antigen [99] . However, substance P release following capsaicin inhalation enhanced airway responses in P-3 infected but not uninfected animals [100] . and Dusser et al [101] suggested that this effect may be mediated by virus-induced decreases in neutral endopeptidase, the enzyme responsible for degradation of substance P. This tachykinin and others may be involved in the evolution of 'neurogenic inflammation', a process that may amplify existing allergic inflammation. Recently it has been shown that the severity of the P-3 infection in guinea pigs is an important factor determining the degree of BHR thai will develop in this model [102] . Similar studies have not been performed using other cold viruses and additional investigations will indicate the role of tachykinins and their catabolism in the mucosa in virusassociated BHR increases and reversible airway obstruction.

Studies in human subjects have studied the effects of various viruses although most investigators have concentrated on HRVs. Empey et al. [15] conducted a prospective study in normal adult subjects and demonstrated increases in BHR after wild-type viral infection presumed to be mostly rhinoviral in origin. Airway reactivity to histamine was increased at the time of clinical viral infection and could be blocked by the use of anticholinergic premedication, leading the authors to postulate that neural mechanisms are implicated in the pathogenesis of BHR increases. A similar study by Jenkins and Breslin [103] in normal and asthmatic subjects failed to confirm the above earlier findings, although individual responses suggested some increases in BHR; however such increases were not significant for the group as a whole.

Other experimental studies in vivo have assessed BHR after infection with HRV (Table 2 ). Halperin et al. [104] first studied normal and atopic volunteers infected with HRV HH and followed this up with a study in 23 [105] . Significant increases in BHR did occur and the results were interpreted by the authorsassuggesting that not all HRVs induce exacerbations of disease in asthmatics and that the role of viral infections in adult wheezing remains uncertain.

Other workers have suggested that alternative mechanisms may be operative in normal versus atopic subjects. An early study of HRV16 infection in normal volunteers could not demonstrate significant changes in BHR, although again all subjects had only mild colds [106] . Using HRVI6. this time in 10 atopic rhinitics, a later study from this group demonstrated increases in histamine and antigen responsiveness which persisted for at least 4 weeks [88] . In addition, late asthmatic reactions (LARs) developed in 8 of 10 subjects during the period of HRV 16 infectivity independently of the development of BHR during the cold. The presence of an atopic diathesis thus appeared to render subjects more vulnerable. These findings may be of particular importance for a large susceptible population of atopic asthmatics who could be at particular risk to develop severe exacerbations of asthma after a preceding bout of 'cold and flu'. The relevant pathophysiological mechanisms underlying these results remain to be explored.

Viruses including H RVs may damage the epithelium of the airways and expose sensory nerve-endings [14] , cause loss of possible protective mediators such as prosta-glandins ET and I2 and epithelium derived relaxant factors [16] and loss of neutral endopeptidases with a local increase in tachykinins [19] . Summers el al. [107] theorized that this possibility may be reflected by an increase in BHR to a probable sensory nerve stimulant such as bradykinin [108] . Twenty-seven normal and atopic subjects were infected with HRV2 or HRV EL; 20 developed mild colds but no increases in BHR to either histamine or bradykinin. Even in six subjects who responded with a more severe 'clinical' cold there were no increases noted on challenge and the findings of Busse et al. [88] could not be corroborated. However, the negative results may be explained by some or all of the following factors: low infecting doses coupled to a different inoculation protocol were applied, different strains of HRVs were used, subjects developed only mild colds and tachyphylaxis may have developed to endogenous bradykinin.

Studies using Influenza A virus have demonstrated the development of BHR more predictably in normal subjects [109, 110] and asthmatics [110] . Clearly there are not only variations in potency within a virus strain such as HRVs. but also differences between individual viruses of different groups. Influenza A causes marked epithelial damage which may result in a more marked tendency for BHR to develop; a situation that may be more pronounced with wild type strains. What is not clear is whether comparable mechanisms determine pulmonary responses to the various types of viruses or whether alternative mechanisms are activated by certain strains. Comparative studies of BHR induced by individual viruses have not been performed and may give some indication of the distinctive inherent bronchial pathogenicity of some strains.

Early studies of killed Influenza vaccines demonstrated increased methacholine sensitivity in asthmatic but not in normal individuals [111] after vaccination. Live attenuated Influenza A vaccine increased histamine induced changes in specific airway conductance 3 days after inoculation; again this response could be abrogated by pretreatment with beta-agonist and anticholinergic medication [110] . These observations could not be confirmed by a later study [112] using another attenuated strain and a different protocol; inoculation was followed by very mild symptoms in only one subject and no symptoms were present in the other 12 tenth day [109] . Significantly, inoculation had been done by aerosol as well as with nasal drops making lower respiratory tract deposition of virus more likely. Respiratory signs and symptoms were notably absent in spite of increases in BHR. Such increases in BHR may nol be restricted to respiratory viruses as suggested by a study of live measles vaccination in chiidren with asthma which indicated that airway responses to methacholine and allergen were amplified; a finding that had disappeared on rechallenge 9 weeks later [113] . The varying degrees of change in BHR reported from difl'erent studies of experimental HRV infection can be explained by large differences in design, diflerences in instilled doses and inoculation protocols and host factors such as age and the presence or absence of atopy ( Table   3 ). The absence of significant lower airway symptoms in the negative studies may be related to the absence of increased BHR after infection, because there is a direct relationship between such symptoms and the clinical severity of HRV infection [lj. The magnitude of changes in BHR may thus be affected by the severity of viral infection as reflected by the presence of symptoms such as cough, wheeze and chest tightness.

For anatomical reasons epithelial damage to the airways may only cause significant impairment of function in small airways; this may only be reflected by changes in reactivity as assessed by specific measurements of small airway function. A study by Picken et al. [114] supported this possibility demonstrating changes in frequency dependent compliance after viral infection.

Measurements of parameters reflecting changes in small airways in subjects with only mild viral infection may therefore demonstrate increases in BHR that would not otherwise be observed.

The upper and lower airways have complimentary roles in Ihe ultimate object of supplying the body with oxygen whilst removing waste products of metabolism. Pathology in one area may trigger a response in another, the physiology of which, in the case of virus-induced asthma exacerbations remains poorly characterized. Viral infection of the upper airways by common cold viruses frequently triggers a response in the lower airways leading 10 prolonged morbidity, especially in subjects with significant pre-existing airway disease. The induction or amplification of BHR may be an important mechanism whereby asthmatic symptoms are produced although the cellular and tissue events or reflex mechanisms activated by viral illnesses and underlying BHR changes are poorly defined and may be dependent on the type and the severity of infection.

Children and asthmatics tend to develop frequent colds setting in motion a sequence of events culminating in airway obstruction and symptoms of wheezing, coughing and chest tightness. This may reflect independent infiammatory changes caused by a simply additive effect of viral damage to the mucosa superimposed upon pre-existing allergic inflammation (Fig. I) . Few if any symptoms will develop in normal subjects with a mild cold whereas significant symptoms may ensue if the cold is severe and induces marked lower airway swelling, secretions and smooth muscle contraction; pathology to which children who have small calibre airways may be particularly susceptible. In asthmatics even a mild cold frequently induces exacerbation of symptoms, while serious lifethreatening asthma attacks may occur associated with a severe cold. Some studies have suggested that this effect is not only additive but also synergistic and brought about by release of the mediators already present in increased quantities, the induction of IgE synthesis, or by the potentiation of neural and epithelial damage. The combined effect of both asthma and viruses may thus be amplified and result in a sustained and refractory period of airway obstruction, severe symptoms and unstable asthma.

As most hospital admissions for asthma occur over the winter months and soon after the start of the school terms [115] , spread of viruses through the community to susceptible individuals may be the single most important cause of sustained exacerbations of asthma. Definition of the pathological and physiological mechanisms involved will lead to better understanding and may thus provide a basis for prevention and the development of effective forms of treatment for virus-induced asthma.

Rhinovirus and influenza type A infections as precipitants of asthma

Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum

Viruses as precipitants of asthma

Virology. New York: Raven Pres

Disturbances of ciliated epithelium due to influenza virus

Tracheobronchial clearance in patients with influenza

Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections

Rhinovirus colds: immunology and pathogenesis

Respiratory virus infection of monolayer cultures of human nasal epithelial cells

Mucociliary function during experimentally induced rhinovirus infection in man

Upper respiratory viral infection and mucociliary clearance

Organ cultures of respiratory epithelium infected with rhinovirus or parainfluenza virus studied in a scanning electron microscope

Shedding of infected ciliated epithelial cells in rhinovirus colds

Neural control of human airways in health and disease

Mechanisms of bronchial hyperreactivity in normal subjects after respiratory traet infection

Epithelial mediators

Regulation by prostanoids

Neuropcptides and asthma

Modulation of neurogenic inflammation by nculrai endopeptidase

Sequential virus infections, bacterial superinfcctions and fibrogenesis

Effect of Influenza A virus on leukocyte hislaminc release

Enhancement of IgE mediated histamine release from human basophils by viruses: role of interferon

Role of interferon in leukocyte histamine release caused by common respiratory viruses

Enhanced basophil histamine release (HR) following in-vitro incubation with live influenza A virus is attenuated by T-cell depletion

The eflecl of parainfluenza 3 infection on guinea pig basophil and lung mast cell histamine release

Interaction of paramyxoviruses with human basophils and their effect on histamine release

Influenza A virus enhances allergic histamine release. Effect of neuraminidase

Rhinovirus upper respiratory infection enhances airway hyperreactivity and basophil histamine releaseability

Enhanced basophil hislamine release (HR) following in-vitro incubation with live rhinovirus

Effect of rhinovirus (RV) 39 infection on responses of the lower airway and the leukocyte

The effect of parainfluenza 3 (P-3) infection on guinea pig (GP) basophils (B)

Virus induced airway hyperresponsiveness in Brown Norway rats is associated with increased numbers of bronchiolar mast cells and bronchiolar wall thickening

Appearance of basophils in the sputum of patients with bronchial asthma

Enhancement of basophil ehemotaxis in vitro by virus induced interferon

Virus and interferon effects on cellular prostaglandin biosynthesis

Klnins in inflammation and tissue injury

Kinins are generated during experimental rhinoviral colds

Complement is activated in the upper respiratory tract during influenza virus infection

Activation of complement by cells infected with respiratory syncytial virus

Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus

Formation of lipoxin A by granulocytes from eosinophilic donors

Fonnation of lipoxins by alveolar macrophages

Biological activities of lipoxin A include lung strip contraction and dilation ofarterioles in vivo

Activation of protein kinase C by lipoxin A and other eicosanoids

Lipoxin A-induced inhibition of human natural killer cell cytotoxicity; studies on stereospecificity of inhibition and mode of action

Lipoxin A; stereochemistry and biosynthesis

Elevated formation of lipoxins in viral antibodypositive rat alveolar macrophages

Identification of lipoxin A and its relationship to the sulfidopeptide leukotrienes d. Da and E4 in the bronchoalveolar fluids obtained from patients with selected pulmonary diseases

Histopathologieal examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinoviral cotds

Nasal-.secretion leukocyte populations determined by flow cytomelry during acute rhinovirus infection

Use of a microtiter assay to demonstrate enhanced neutrophii adhesion to human airway epithelial cells infected with respiratory viruses

Activation of oxidative and arachidonic acid metabolism in ncutrophils by respiratory syncytial virus antibody complexes: possible role in disease

Antibody dependent enhancement of viral infectivity

Productive infection of isolated human alveolar macrophages by Respiratory Syncytial Virus

Serum and secretory antibody response of normal and asthmatic subjects to influenza vaccine

Acute-phase decrease of T-lymphocyte subsets in rhinovirus infection

T-cells. interferon and rhinovirus infection

IgE production by normal lymphocytes is induced by interleukin 4 and suppressed by intcrferons and prostaglandin E?

Development of low density eosinophiis (Eos) following in vitro incubation with respiratory viruses

Role of Respiratory Syncytial Virus-induced eosinophil degranulation in bronchiolitis

Experiment rhinovirus 16 infection potentiates airway inflammation only in allergic subjects

Peripheral blood mononuclear cell interleukin-2 and interferon-y production, cytotoxicity and antigen-stimulated blastogenesis during experimental rhinovirus infection

Rubenis M. Specific mononuclear cell response to rhinovirus

Cell-mediated immune responses to respiratory syneytial virus infection: relation-.ship to the development of reactive airways disease

The beta-adrenergic theory of atopie abnormality in asthma

Pharmacologic effects of epinephrine in asthmatic children

Correlation between increased bronchial response to acetylcholine and diminished metabolic and eosinopenic responses to epinephrine in asthma

Pi-Sunver RX. Comparison of the circulatory and metabolic effects of isoprotercnol, epinephrine and methoxamine in normal and asthmatic subjects

Decreased granulocyte response to isoproterenol in asthma during upper respiratory infection

In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity

Viral pneumonia attenuates adenylate cyclasc but not beta-adrenergic receptors in murine lung

The development of respiratory syncytial virus-specific IgE and the release ofhistamine in nasopharyngeal secretion after infection

The appearance of cellbound IgE in respiratory traet epithelium after respiratory syneytial virus infection

Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection

IgE antibodies to Mycoplasma pneumoniae in asthma and other atopic diseases

Inflammatory cells in allergic disease

Mast cell lines produce lymphokines in response to cross linkage of FCfiRI or to calcium ionophores

Eflect of respiratory and other virus infections on IgE immunoregulation

Development of allergy in children. I. Association with virus infections

EflTect of influenza virus infection on allergic sensitisation to aerosolised ovalbumin in mice

Effect of attenuated measles virus vaccination on modulation of T-ceil subsets

Functional diversity of T lymphocytes due to secretion of different cytokine patterns

Induction of human IgE synthesis by a factor derived from T-cells of patients with hyper IgE states

Pattertis of illness in rhinovirus infections of military personnel

Etiology of upper respiratory tract illness among civilian adults

Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses

Rhinovirus upper respiratory tract infection increases airway hyperreactivity and late asthmatic reactions

Rhinovirus and influenza type A infections as precipitants of asthma

Exacerbations of asthma in adults during experimental rhinovirus infection

Direct recordings of the temperature in the tracheobronchial tree in normal man

Pulmonary infeetion due to rhinovirus type 13

Sudden death of an infant with rhinovirus infection complicating bronchial asthma

Latent herpesvirus-6 in salivary and bronchial glands

The shape of the doseresponse curve to histamine in normal and asthmatic subjects

Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma

The interrelationship among bronchial hyper responsiveness, the diagnosis of asthma, and asthma symptoms

Airway hyperresponsiveness. Relevance of random population data to clinical usefulness

Parainfiuenza 3 blocks the ability of a beta-receptor agonist to inhibit antigen-induced contraction of isolated guinea pig airway smooth muscle

Enhancement by parainfluenza 3 infection of contractile responses to substance P and eapsaicin in airway smooth muscle from the guinea pig

Virus induces airway hyper responsiveness to tachykinins: role of neutral endopeptidase

Parainfiuenza III (P3) virus infection causes airway hyperresponsiveness to intravenous substance P in guinea pigs

Upper respiratory tract symptoms in experimental rhinovirus infection

Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection

Viral infection in adults with chronic asthma

Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects

Bronchial reactivity to inhaled histamine and bradykinin in dtopk and non-atopic normal volunteers after experimental rhinovirus infection

Bradykinin-induced bronchoconstriction in humans

Bronchial hyperresponsiveness in normal subjects during attenuated Influenza virus infeetion

Bronchial reactivity following uncomplicated influenza A infection in healthy subjects and in asthmatic patients

Increased response of asthmatic subjects to methacholine after influenza vaccine

Bronchial hyperreactivity and bronchial obstruction in respiratory viral infection

Effect of live measles vaccination on bronchial sensitivity of asthmatic children to methacholin

Prolonged effect of viral infection of the upper respiratory tract upon small airways

School holidays and admissions with asthma